JTC Team to Host Virtual Investor Innovations in Oncology - Ongoing Pivotal Global Study for Treatment of Glioblastoma Multiforme (GBM) Featuring CNS Pharmaceuticals
ACCESSWIRE
24 Sep 2022, 02:37 GMT+10
Live moderated video webcast with management Management to discuss potentially pivotal global study of lead asset, Berubicin, on Wednesday, September 28th at 1:00 PM ET
FRENCHTOWN, NJ / ACCESSWIRE / September 23, 2022 / JTC Team ('JTC'), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Innovations in Oncology - Ongoing Pivotal Global Study for Treatment of Glioblastoma Multiforme (GBM) Event on Wednesday, September 28, 2022 at 1:00 PM ET. Access the event here.
CNS Pharmaceuticals a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system malignancies. The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer.
In addition to the moderated portion of the event, investors and interested parties will have the opportunity to submit questions. The Company will answer as many questions as possible during the event.
A live video webcast of the Virtual Investor Innovations in Oncology featuring CNS Pharmaceuticals will be available on virtualinvestorco.com. A webcast replay will be made available shortly after the conclusion of the live event and will be accessible for 90 days.
About JTC Team
JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.
Contact:
Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com
SOURCE: JTC Team, LLC
View source version on accesswire.com:
https://www.accesswire.com/717218/JTC-Team-to-Host-Virtual-Investor-Innovations-in-Oncology--Ongoing-Pivotal-Global-Study-for-Treatment-of-Glioblastoma-Multiforme-GBM-Featuring-CNS-Pharmaceuticals
Subscribe and Follow
Get a daily dose of Orange County Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
News RELEASES
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Orange County Sun.
More Information
43
℉
Unrecyclable plastic can now be recycled
Washington [US], December 3 (ANI): PVC, or polyvinyl chloride, is one of the most produced plastics in the United States ...
China blasts US for coercive diplomacy
Beijing responded after Washington's top diplomat accused China of preparing a military build-upChina has called on the US to drop ...
White House Says Biden Not Intending to Talk to Putin
The White House said U.S. President Joe Biden has 'no intentions' at present of holding negotiations with President Vladimir Putin ...
Biden Signs Bill Averting Strike, to Rail Unions' Dismay
Congress and the Biden administration this week used the provisions of a 96-year-old labor law to force unions representing thousands ...
Prince William, Like His Father, Prioritizes the Environment
boston - Britain's Prince William capped a three-day visit to Boston by meeting with U.S. President Joe Biden on Friday, ...
VOA Interview December 2: John Kirby
white house - VOA White House correspondent Paris Huang spoke with John Kirby, National Security Council (NSC) Coordinator for Strategic ...
China will have 1,500 nuclear warheads by 2035, Pentagon warns
WASHINGTON, D.C.: According to a Pentagon report, if China continues with its current nuclear buildup pace, it could have a ...
China seeks to dominate space, warns US general
SYDNEY, Australia: Lt. General Nina Armagno of the U.S. Space Force has said that rapid advancements in China's military capabilities ...
William, Kate plan US trip in bid to tamp down royal controversies
LONDON, England: Prince William and his wife Kate, the new Prince and Princess of Wales, will travel to the U.S. ...
Citing lessening risks, Australia lowers threat levels
SYDNEY, Australia: For the first time in eight years, Australia lowered its terrorism threat level from "probable" to "possible," due ...
Some protest plan to thin New Jersey forest to protect from fire
TRENTON, New Jersey: As part of a project to prevent major wildfires in a federally protected New Jersey forest, up ...
Failed negotiations results in 1 day rail strike in Austria
VIENNA, Austria: During a 24-hour strike by Austrian rail workers held this week over issues related to pay, rail traffic ...
